The optimal timing and duration of daily G-CSF for primary prophylaxis after adjuvant TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy in breast cancer patients

Autor:	Jeong Eon Lee, S.Y. Kim, C.W. Lim, Sae-Won Han, Z. Kim, Jung-Shin Lee, S.M. Hur
Rok vydání:	2019
Předmět:	Oncology medicine.medical_specialty Chemotherapy Cyclophosphamide business.industry medicine.medical_treatment General Medicine medicine.disease Breast cancer Internal medicine Docetaxel/doxorubicin medicine Surgery business Adjuvant medicine.drug
Zdroj:	The Breast. 44:S18
ISSN:	0960-9776
DOI:	10.1016/s0960-9776(19)30111-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::47300aa249e260f59a7858b9482b97ee https://doi.org/10.1016/s0960-9776(19)30111-0 Zobrazit plný text záznamu Full Text from ScienceDirect